Literature DB >> 31986536

Preeclampsia: The Need for a Biological Definition and Diagnosis.

Alex C Vidaeff1, George R Saade2, Baha M Sibai3.   

Abstract

The centuries-old approach to the prevention of eclampsia and its associated maternal morbidity and mortality is based on the recognition of the presence of premonitory signs and symptoms such as hypertension and proteinuria. The spectrum of preceding signs and symptoms came to be known as preeclampsia, which is debatably considered to be an early stage on a clinical continuum possibly leading to eclampsia. The premonitory signs and symptoms were then construed as diagnostic criteria for the poorly understood syndrome of preeclampsia, and this led to a perpetual debate that remains subject to wide disagreement and periodic updates. In this commentary, we will draw attention to the fact that the criteria for preeclampsia should be viewed from the prism of a screening test rather than as diagnostic of a condition in itself. Focusing research on developing better diagnostic and screening methods for what is clinically important, namely maternal and perinatal morbidity and mortality from hypertensive disorders of pregnancy, a long overdue upgrade from what was possible centuries ago, will ultimately lead to better management approaches to what really matters. Thieme. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 31986536     DOI: 10.1055/s-0039-1701023

Source DB:  PubMed          Journal:  Am J Perinatol        ISSN: 0735-1631            Impact factor:   1.862


  2 in total

1.  Health Care Readiness in Management of Preeclampsia/Eclampsia in Ethiopia: Evidence from National Facility-Based Survey.

Authors:  Maereg Wagnaw Meazaw; Catherine Chojenta; Peta Forder; Tefera Taddele; Deborah Loxton
Journal:  Risk Manag Healthc Policy       Date:  2022-06-16

2.  Conformation-dependent anti-Aβ monoclonal antibody signatures of disease status and severity in urine of women with preeclampsia.

Authors:  Rosa S Valtanen; Catalin S Buhimschi; Mert O Bahtiyar; Guomao Zhao; Hongwu Jing; William E Ackerman; Charles G Glabe; Irina A Buhimschi
Journal:  Pregnancy Hypertens       Date:  2022-02-03       Impact factor: 2.494

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.